1972
DOI: 10.1136/thx.27.4.401
|View full text |Cite
|
Sign up to set email alerts
|

Pathology of the formalin-treated heterograft porcine aortic valve in the mitral position

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
6
0

Year Published

1975
1975
2004
2004

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 30 publications
(6 citation statements)
references
References 17 publications
(15 reference statements)
0
6
0
Order By: Relevance
“…[1][2][3] Historically, to avoid immune-response-related rejection and to stabilize the xenogenic matrix, porcine valves were treated with formaldehyde; although these valves were an improvement over nontreated bioprostheses, they degraded after implantation. 4,5 Subsequently, along with aldehyde-based crosslinking chemistry, glutaraldehyde treatment became the standard process for preserving and stabilizing xenografts for clinical use. [1][2][3] There is a long and successful clinical history of glutaraldehyde-treated bioprosthetic heart-valve use.…”
Section: Introductionmentioning
confidence: 99%
“…[1][2][3] Historically, to avoid immune-response-related rejection and to stabilize the xenogenic matrix, porcine valves were treated with formaldehyde; although these valves were an improvement over nontreated bioprostheses, they degraded after implantation. 4,5 Subsequently, along with aldehyde-based crosslinking chemistry, glutaraldehyde treatment became the standard process for preserving and stabilizing xenografts for clinical use. [1][2][3] There is a long and successful clinical history of glutaraldehyde-treated bioprosthetic heart-valve use.…”
Section: Introductionmentioning
confidence: 99%
“…Few patients have been followed up for more than five years at the present time. While calcification of fresh aortic homograft valves may be a significant problem (Smith, 1967;Davies et al, 1968), this was not encountered with formalin-treated xenografts (Ionescu et al, 1968;Rose, 1972). Roberts (1976) The severe calcification in our patient's xenograft one year after implantation is very disturbing.…”
Section: Discusionmentioning
confidence: 74%
“…Historically, to avoid immune responserelated rejection and to stabilize the xenogenic matrix, valve tissues were treated with formaldehyde, which, although an improvement over nontreated bioprostheses, were found to degrade after implantation. 5,6 Subsequently, and also using aldehyde-based crosslinking chemistry, glutaraldehyde treatment became the standard process in preserving and stabilizing xenografts for clinical use. 1,2 There has been a long and successful clinical history for glutaraldehydetreated bioprosthetic heart valves with this treatment remaining the method of choice and the only proven technology for long-term tissue stabilization.…”
Section: Introductionmentioning
confidence: 99%